Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome
about
Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT.Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1.Impact of clinical factors on outcome of leukemia patients with TLS-ERG fusion gene.
P2860
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Allogeneic hematopoietic cell ...... ramedullary disease on outcome
@ast
Allogeneic hematopoietic cell ...... ramedullary disease on outcome
@en
type
label
Allogeneic hematopoietic cell ...... ramedullary disease on outcome
@ast
Allogeneic hematopoietic cell ...... ramedullary disease on outcome
@en
prefLabel
Allogeneic hematopoietic cell ...... ramedullary disease on outcome
@ast
Allogeneic hematopoietic cell ...... ramedullary disease on outcome
@en
P2093
P2860
P50
P356
P1476
Allogeneic hematopoietic cell ...... ramedullary disease on outcome
@en
P2093
B N Savani
D J Weisdorf
D S Ritchie
D W Bunjes
E A Copelan
P2860
P2888
P304
P356
10.1038/BMT.2015.82
P407
P577
2015-04-27T00:00:00Z